3)qmGTCACCAGCAAATCGCGCTGTTAGCGGGCCCATTAAGTTCTGTCTCGGCGCGTCTGCGTCTGGCTGGCTGGCATAAATATCTCACTCGCAATCAAATTCAGCCGATAGCGGAACGGGAAGGCGACTGGAGTGCCATGTCCGGTTTTCAACAAACCATGCAAATGCTGAATGAGGGCATCGTTCCCACTGCGATGCTGGTTGCCAACGATCAGATGGCGCTGGGCGCAATGCGCGCCATTACCGAGTCCGGGCTGCGCGTTGGTGCGGATATCTCGGTAGTGGGATACGACGATACCGAAGACAGCTCATGTTATATCCCGCCGTCAACCACCATCAAACAGGATTTTCGCCTGCTGGGGCAAACCAGCGTGGACCGCTTGCTGCAACTCTCTCAGGGCCAGGCGGTGAAGGGCAATCAGCTGTTGCCCGTCTCACTGGTGAAAAGAAAAACCACCCTGGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGCTTCCGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTATGACCATGATTACGGATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGCGCTTTGCCTGGTTTCCGGCACCAGAAGCGGTGCCGGAAAGCTGGCTGGAGTGCGATCTTCCTGAGGCCGATACTGTCGTCGTCCCCTCAAACTGGCAGATGCACGGTTACGATGCGCCCATCTACACCAACGTAACCTATCCCATTACGGTCAATCCGCCGTTTGTTCCCACGGAGAATCCGACGGGTTGTTACTCGCTCACATTTAAACGTTATCGACTGCACGGTGCACCAATGCTTCTGGCGTCAGGCAGCCATCGGAAGCTGTGGTATGGCTGTGCAGGTCGTAAATCACTGCATAATTCGTGTCGCTCAAGGCGCACTCCCGTTCTGGATAATGTTTTTTGCGCCGACATCATAACGGTTCTGGCAAATATTCTGAAATGAGCTGTTGACAATTAATCATCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGTATTCATGTCCCCTATACTAGGTTATTGGAAAATTAAGGGCCTTGTGCAACCCACTCGACTTCTTTTGGAATATCTTGAAGAAAAATATGAAGAGCATTTGTATGAGCGCGATGAAGGTGATAAATGGCGAAACAAAAAGTTTGAATTGGGTTTGGAGTTTCCCAATCTTCCTTATTATATTGATGGTGATGTTAAATTAACACAGTCTATGGCCATCATACGTTATATAGCTGACAAGCACAACATGTTGGGTGGTTGTCCAAAAGAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGGTTTTGGATATTAGATACGGTGTTTCGAGAATTGCATATAGTAAAGACTTTGAAACTCTCAAAGTTGATTTTCTTAGCAAGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATGTCATAAAACATATTTAAATGGTGATCATGTAACCCATCCTGACTTCATGTTGTATGACGCTCTTGATGTTGTTTTATACATGGACCCAATGTGCCTGGATGCGTTCCCAAAATTAGTTTGTTTTAAAAAACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAGCAAGTATATAGCATGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGGCGACCATCCTCCAAAATCGGATCTGATCGAAGGTCGTGGgatcccatggtatgtctcttatatcacccgaccagaggcagaagctgctctgaggaagataaaccaggatggcaccttcctggttagagacagctctaagaagacagcgaacaatccgtatgtcctcatggtgctgtacaaagacaaagtttacaacatccaaatccgctaccaggaggaaagtcaagtctacttgttgggcactggacttcgaggaaaagaggacttcctgtctgtatcagatattattgactacttcaggaaaatgccgctgttgctcattgatggaaagaatcgagggtccagataccagtgcacactaacacacgctgcaggctgtctggAATTCATCGTGACTGACTGACTGACGATCTGCCTCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCGCAGCCATGACCCAGTCACGTAGCGATAGCGGAGTGTATAATTCTTGAAGACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAATGTCATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGCAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATAAATTCCGACACCATCGAATGGTGCAAAACCTTTCGCGGTATGGCATGATAGCGCCCGGAAGAGAGTCAATTCAGGGTGGTGAATGTGAAACCAGTAACGTTATACGATGTCGCAGAGTATGCCGGTGTCTCTTATCAGACCGTTTCCCGCGTGGTGAACCAGGCCAGCCACGTTTCTGCGAAAACGCGGGAAAAAGTGGAAGCGGCGATGGCGGAGCTGAATTACATTCCCAACCGCGTGGCACAACAACTGGCGGGCAAACAGTCGTTGCTGATTGGCGTTGCCACCTCCAGTCTGGCCCTGCACGCGCCGTCGCAAATTGTCGCGGCGATTAAATCTCGCGCCGATCAACTGGGTGCCAGCGTGGTGGTGTCGATGGTAGAACGAAGCGGCGTCGAAGCCTGTAAAGCGGCGGTGCACAATCTTCTCGCGCAACGCGTCAGTGGGCTGATCATTAACTATCCGCTGGATGACCAGGATGCCATTGCTGTGGAAGCTGCCTGCACTAATGTTCCGGCGTTATTTCTTGATGTCTCTGACCAGACACCCATCAACAGTATTATTTTCTCCCATGAAGACGGTACGCGACTGGGCGTGGAGCATCTGGTCGCATTGGm$ k$    5 k 5m kTm $ 5   $ `  6(w9  w`   $ ` [-`  ZL;! ! T t  h ! 0`  JnV `  ' `  ~ `  (Ropen reading frame#1GST>product="glutathione S-transferase" /protein_id="ABO28844.1"  lactamase CDSFxFactor X cleavage site pGEX-pRP261(Seba)=Entered into Gene Construction Kit by Keith Johnson, 9/4/91. ampR tac promoterpUC ori }pUC ori is equivalent to pBR322 ori; the origin of replication (ori) was derived originally from a ColE1-like plasmid, pMB1 SH2-SLP76>ref|NM_010696.3| Mus musculus lymphocyte cytosolic protein 2 (Lcp2), mRNA, Fragment 472-584aa, ( complete 585aa) GENE ID: 16822 Lcp2 | lymphocyte cytosolic protein 2 [Mus musculus] m$, ()F$H:ÿ+˜ ()$HżdW () &$ ?| ()v| $ ()SHincIIIsoschizomer with HindII, ChuII, Hin1160II, Hin1161II, HinJCI, and MnnI. Available from Invitrogen Corporation (8/08), Fermentas International Inc. (8/08), American Allied Biochemical, Inc. (8/08), Nippon Gene Co., Ltd. (8/08), Takara Bio Inc. (8/08), New England Biolabs (8/08), Toyobo Biochemicals (8/08), Molecular Biology Resources - CHIMERx (8/08), Promega Corporation (8/08), Bangalore Genei (8/08), MP Biomedicals (8/08), EURx Ltd. (8/08), and CinnaGen Inc. (8/08). BamHI5Isoschizomer with AacI, AaeI, AcaII, AccEBI, AinII, AliI, Ali12257I, Ali12258I, ApaCI, AsiI, AspTII, Atu1II, BamFI, BamKI, BamNI, Bca1259I, Bce751I, Bco10278I, BnaI, BsaDI, Bsp30I, Bsp46I, Bsp90II, Bsp98I, Bsp130I, Bsp131I, Bsp144I, Bsp4009I, BspAAIII, BstI, Bst1126I, Bst2464I, Bst2902I, BstQI, Bsu90I, Bsu8565I, Bsu8646I, BsuB519I, BsuB763I, CelI, DdsI, GdoI, GinI, GoxI, GseIII, GstI, MleI, Mlu23I, NasBI, Nsp29132II, NspSAIV, OkrAI, Pac1110I, Pae177I, Pfl8I, Psp56I, RhsI, Rlu4I, RspLKII, SolI, SpvI, SurI, Uba19I, Uba31I, Uba38I, Uba51I, Uba88I, Uba1098I, Uba1163I, Uba1167I, Uba1172I, Uba1173I, Uba1205I, Uba1224I, Uba1242I, Uba1250I, Uba1258I, Uba1297I, Uba1302I, Uba1324I, Uba1325I, Uba1334I, Uba1339I, Uba1346I, Uba1383I, Uba1398I, Uba1402I, Uba1414I, Uba4009I, and UbaN3I. Available from Invitrogen Corporation (8/08), Minotech Biotechnology (8/08), Fermentas International Inc. (8/08), American Allied Biochemical, Inc. (8/08), SibEnzyme Ltd. (8/08), Nippon Gene Co., Ltd. (8/08), Takara Bio Inc. (8/08), Roche Applied Science (8/08), New England Biolabs (8/08), Toyobo Biochemicals (8/08), Molecular Biology Resources - CHIMERx (8/08), Promega Corporation (8/08), Sigma Chemical Corporation (8/08), Bangalore Genei (8/08), Vivantis Technologies (8/08), MP Biomedicals (8/08), EURx Ltd. (8/08), and CinnaGen Inc. (8/08). NcoI'Isoschizomer with AteI, Bse19I, Bsp19I, and NspSAIII. Available from Invitrogen Corporation (8/08), Minotech Biotechnology (8/08), Fermentas International Inc. (8/08), American Allied Biochemical, Inc. (8/08), Nippon Gene Co., Ltd. (8/08), Takara Bio Inc. (8/08), Roche Applied Science (8/08), New England Biolabs (8/08), Toyobo Biochemicals (8/08), Molecular Biology Resources - CHIMERx (8/08), Promega Corporation (8/08), Sigma Chemical Corporation (8/08), Bangalore Genei (8/08), MP Biomedicals (8/08), EURx Ltd. (8/08), and CinnaGen Inc. (8/08). EcoRIIsoschizomer with Eco82I, Eco159I, Eco228I, Eco237I, Eco252I, FunII, HalI, Hal22I, Kpn49kI, Ppu111I, RsrI, Srl32DII, Srl55DI, SsoI, Uba58I, Van91II, VchN100I, and VchO2I. Available from Invitrogen Corporation (8/08), Minotech Biotechnology (8/08), Fermentas International Inc. (8/08), American Allied Biochemical, Inc. (8/08), SibEnzyme Ltd. (8/08), Nippon Gene Co., Ltd. (8/08), Takara Bio Inc. (8/08), Roche Applied Science (8/08), New England Biolabs (8/08), Toyobo Biochemicals (8/08), Molecular Biology Resources - CHIMERx (8/08), Promega Corporation (8/08), Sigma Chemical Corporation (8/08), Bangalore Genei (8/08), Vivantis Technologies (8/08), MP Biomedicals (8/08), EURx Ltd. (8/08), and CinnaGen Inc. (8/08). HincIIIsoschizomer with HindII, ChuII, Hin1160II, Hin1161II, HinJCI, and MnnI. Available from Invitrogen Corporation (8/08), Fermentas International Inc. (8/08), American Allied Biochemical, Inc. (8/08), Nippon Gene Co., Ltd. (8/08), Takara Bio Inc. (8/08), New England Biolabs (8/08), Toyobo Biochemicals (8/08), Molecular Biology Resources - CHIMERx (8/08), Promega Corporation (8/08), Bangalore Genei (8/08), MP Biomedicals (8/08), EURx Ltd. (8/08), and CinnaGen Inc. (8/08). mm.0 (Most Recent Generation) (Oldest Generation)  = ()   = () GGTCACCGGTCACCpRP-GST-SH2SLP76BL219Toolbox verified plasmid via restriction digest 10-2009. Standard Codon Table     k  (` () *?3) d'[((62.822B8$$